Further research has identified that dextran sulfate targets HIF-1α, inhibiting EMT in gastric cancer cells at both mRNA and protein levels, suggesting that HIF-1α and dextran sulfate hold promise for gastric cancer immunotherapy (114). The gene discussed is HIF1A; the disease is gastric cancer.